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Background: Persons with severe mental illness often face difficulties in accessing and
receiving adequate services enabling them to live independently. Many have co-occurring
substance use problems that increase the risk of adverse outcomes. Community-based
service models have been implemented around the world, including assertive community
treatment (ACT), but the knowledge of rehabilitation outcomes in different subgroups is
limited. We aimed to explore rehabilitation outcomes among patients suffering severe
mental illness with and without substance use problems who had received ACT services
for at least 2 years. Additionally, we compared differences in changes between the
two groups.
Methods: A total of 142 patients who received services for 2 years from the first 12
Norwegian ACT teams were included. Eighty-four (59%) had problematic substance
use, while 58 (41%) did not. Data regarding housing, activity, symptoms, functioning,
and subjective quality of life were collected upon enrollment into ACT and at 2 years
of follow-up. Clinician-rated scales and self-report questionnaires were used. Changes
within the two groups and differences in change between the groups were assessed
using generalized linear mixed models.
Results: Both groups were more likely to have good housing, higher level of
functioning, and less anxiety and depressive symptoms after 2 years. The odds of
good housing among participants with problematic substance use increased only after
adjusting for age and gender. Participants with problematic substance use had less
severe symptoms, particularly negative and manic symptoms, while participants without
problematic substance use reported improved satisfaction with life in general. Neither
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group experienced a change in having a meaningful daily activity, positive symptoms,
practical and social functioning, or subjective quality of life. The reduction of manic
symptoms in the substance use group was the only difference between the groups.
Conclusion: After 2 years, patients with and without problematic substance
use experienced improvements in several important domains. Furthermore, the
improvements were similar in both groups for most outcomes. This may suggest that
ACT has a place in the continued effort toward integrated and comprehensive community
services empowering patients with severe mental illness to achieve and sustain an
independent life, including marginalized groups with severe substance use.
Keywords: severe mental illness, co-occurring substance use, assertive community treatment, housing, activity,
psychiatric symptom, functioning, quality of life
INTRODUCTION
Persons with severe and persistent mental illness often struggle
with having their needs met by the service system, and
health care services often face difficulties in reaching, engaging,
and providing services that enable them to live their lives
independently in the community. Co-occurring substance use
disorders are frequent in this population (1–5), and they increase
the risk of adverse outcomes, including relapse or worsening of
psychiatric symptoms (6–8), impaired functioning (5, 6), housing
instability (9), and lower quality of life (7, 8). Over the past
decades, many countries have implemented integrated models of
mental health care to improve services for persons with severe
mental illness and complex needs (10), including co-occurring
substance use problems.
The overarching goal of mental health rehabilitation services
for persons with severe and complex mental health conditions is
to provide high-quality services that promote recovery and that
are based on the patients’ needs, wishes, and active participation
(11, 12). Appropriate interventions that target a range of factors
on an individual level and are provided in the community are
needed to improve rehabilitation outcomes and to promote
recovery for this group (13). Although the shift from institution-
based and fragmented services to integrated, community-based
services started decades ago, the services are still insufficient,
leading both theWorldHealthOrganization (WHO) (14) and the
United Nations (UN) (15) to recently emphasize the continuous
need to “invest in psychosocial services that are integrated
into primary care and community services to empower users
and respect their autonomy” (15). A fragmented service system
and traditional office-based mental health care, even when
localized in the community, may present obstacles to delivering
comprehensive and coordinated services, as was the situation in
Norway in the early 2000s (16).
One multidisciplinary, team-based, and intensive service
delivery program with a strong focus on providing services
to improve their patients’ abilities to achieve and sustain an
independent life in the community is the assertive community
treatment (ACT) model (17). ACT teams target persons with
severe mental illness, including persons with co-occurring
substance use disorders (18, 19), who have complex needs and
difficulties in engaging with standard care. These teams use
multiple strategies to reach and keep in contact with their
patients. High-fidelity teams provide psychosocial and outreach
services that are based on the patients’ wishes and needs,
and the services are evidence-based, individually tailored, and
recovery-oriented (20). The implementation of ACT teams in the
Norwegian health care system started in 2007 andwas included in
a white paper in 2009 (21). A main aim was to integrate different
health and welfare services to improve treatment for persons
with severe mental illness in need of comprehensive and long-
term care (16), including persons with co-occurring substance
use problems.
Integrated multiple interventions have been found superior
over single interventions in improving outcomes for persons
with schizophrenia (13). Among persons with co-occurring
substance use disorders, they have shown to improve drop
out of services, symptom severity, substance use, and housing
conditions (22). High-fidelity ACT teams seem to be somewhat
better in improving substance use problems and reducing
high use of inpatient care than low-fidelity teams, but
ACT has not been shown to significantly improve other
outcomes over non-intensive or standard care (22). The lack
of effect may partly be explained by the heterogeneity of
the included studies (19, 22, 23), or that there are too
many organizational similarities between the control services
and the experimental (ACT) services (23, 24). However, the
included studies did not compare outcomes between different
subgroups. A recent study comparing outcomes between
persons with co-occurring substance dependence, co-occurring
substance abuse, or no substance use found that all groups
experienced improved outcomes (25). Nevertheless, patients
with co-occurring dependence showed less improvements in
psychiatric symptoms, level of functioning, and quality of life
than patients with substance abuse or patients without substance
use problems (25). Further studies are needed to increase our
knowledge of rehabilitation outcomes among different subgroups
of patients with severe mental illness who receive integrated and
community-based services such as ACT, including those with
co-occurring substance use disorders.
In the current study, we aimed to explore if outcomes
associated with rehabilitation changed for patients both with and
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without problematic substance use after 2 years with ACT. The
outcomes we included were housing situation, meaningful daily
activity, severity of psychiatric symptoms, level of functioning,
and subjective quality of life.
Our research questions were as follows:
1. Do patients with and without problematic substance use
experience changes in rehabilitation outcomes after 2 years
of ACT follow-up compared to the situation upon enrollment
into the teams?
2. Are any changes in rehabilitation outcomes different for
patients with problematic substance use compared to patients
without problematic substance use?
METHODS
Design
This study is part of the research-based evaluation of ACT teams
in Norway. It has a prospective cohort design and includes data
from patients upon their enrollment into ACT and after 2 years
of follow-up.
Setting
From 2009 until 2011, 12 ACT teams were established
throughout Norway in both rural and urban areas. Details
regarding the setting and differences between the teams,
including fidelity to the ACT model, have been published earlier,
but relevant information is repeated here: Fidelity was measured
using the Tool for Assertive Community Treatment fidelity scale
(TMACT) (26). The mean fidelity scores at 12 months ranged
from 2.7 to 3.7, indicating low to moderate fidelity to the ACT
model. At 30months, the scores ranged from 3.1 to 4.1, indicating
moderate to high fidelity. Substance abuse specialist was present
in 11 teams at 12 and 30 months’ fidelity evaluation. The
mean fidelity scores on the five subscales relating to substance
abuse specialist and Integrated Dual Disorder Treatment (IDDT)
showed moderate to high fidelity. However, the scores on the
different items showed large variations between teams (scores
ranged 1–5, indicating none to full implementation) (27, 28).
Recruitment and Participants
The recruitment process and the characteristics of the
participants, including the classification of problematic
substance use, have been described in detail elsewhere (28).
However, a brief description is provided: The ACT teams
included 338 patients during their first year of operation, and
178 (53%) gave written informed consent to participate in our
study. After 2 years of follow-up, 16 of the 178 patients were
discharged from the teams, five patients had died, and for 12
participants, no data were shared with the research group despite
written informed consent. This left a total of 142 (42%) who
had received ACT services for at least 2 years and provided the
research group with data from both enrollment and after 2 years
of follow-up. Compared to the nonparticipants (n = 196, 58%),
fewer participants had problematic substance use and they had
less severe symptoms and better functioning. There were no
differences in age, gender, diagnosis of severe mental illness,
or people being subject to involuntary outpatient treatment
between participants and nonparticipants (28).
Characteristics of the participants have been presented in
Norwegian earlier (27), but a short summary is included here.
Upon enrollment into the teams, the mean age of the participants
was 40 years [standard deviation (SD) 8.7] and the majority
was male (n = 94, 67%), of Norwegian origin (n = 114,
84%), unmarried (n = 106, 75%), and more than half was
living alone (n = 86, 61%). Seventeen percent (n = 33) were
either living in institutions or homeless. Almost all participants
had a severe mental illness according to the criteria of the
International Statistical Classification of Diseases and Related
Health Problems (ICD), 10th revision (29), where schizophrenia-
spectrum disorders were the most common (F20–29 n = 115,
87%) and a few participants had bipolar disorder (F31) (n = 9,
7%). Approximately one third was under involuntary outpatient
treatment (n = 51, 36%). Of the 142 participants, 84 (59%) were
classified as having problematic substance use upon enrollment
into the ACT teams, while 58 (41%) were not. Further details
regarding the classification and characteristics of the two groups
have been published in the previously mentioned paper (28), but
the categorization and the main differences between the groups
are repeated here. Classification of problematic substance use was
based on the participants’ self-report of alcohol and substance
use [the Alcohol Use Disorder Identification Test (AUDIT) and
the Drug Use Disorder Identification Test (DUDIT) scales; for
more information, see the following paragraph–Measures]. A
total of 72 participants (51%) scored above cutoff on one or both
scales. For participants who scored below cutoff or who had not
completed the AUDIT or the DUDIT, we included the clinician-
rated scores on the Alcohol Use Scale (AUS) and the Drug Use
Scale (DUS) (for more information, see the following paragraph–
Measures). When the score was 3 or higher on one or both scales,
the participants were assigned to the “problematic substance use”
group (28).
The participants with problematic substance use were more
likely to be of Norwegian origin than the participants without
problematic substance use; they had a lower level of education;
they weremore often subject to involuntary outpatient treatment;
they had more severe psychiatric symptoms, particularly manic
symptoms; and they had a lower level of everyday functioning.
There were no differences between the groups regarding gender,
age, employment status, living situation, or level of global
functioning (GAF-F) upon enrollment. After 2 years of follow-
up by ACT, six (7%) of the 84 participants who were classified as
having problematic substance use upon enrollment into ACT no
longer meet the criteria. We also found that four (7%) of the 58
participants who did not meet the criteria upon enrollment were
classified as having problematic substance use 2 years after.
Measures
Clinician-Rated Instruments
Sociodemographic data were collected by the teams using
a registration form on their life situation and health that
included questions regarding the patients’ housing situation and
occupational/educational activities. The ACT teams categorized
the participants’ housing situation as “Very poor” = 0, “Poor”
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= 1, “Neither poor nor good” = 2, “Good” = 3, or “Very good”
= 4 based on their knowledge and observations. Due to few
participants in some categories, we dichotomized the variable
into “Poor” (including 0, 1, and 2) and “Good” (including 3 and
4) for the analyses.
The ACT teams also assessed the patients’ activity situation,
including competitive work, supported or sheltered work,
studying, unemployment, admitted or incarcerated, or other
activities during the last 4 weeks before enrollment and during
the last 4 weeks before the 2-year assessment. We dichotomized
the variable into “Meaningful daily activity–Yes/No,” where
“Yes” included competitive work, sheltered/supported work, and
studying, while “No” included unemployment, admissions in
institution, or incarceration. This was done due to a very low
number of participants in several categories.
Psychiatric symptoms were assessed by the ACT teams
using the Brief Psychiatric Rating Scale–Expanded version
(BPRS-E) (30). This is a 24-item rating scale, and each
item is given a score from 1 (not present) to 7 (extremely
severe). The 24 items give four symptom-dimensions, including
positive symptoms (grandiosity, suspiciousness, hallucinations,
unusual thought content, bizarre behavior, disorientation, and
conceptual disorganization), negative symptoms (blunted affect,
emotional withdrawal, and motor retardation), agitation mania
(tension, uncooperativeness, excitement, distractibility, motor
hyperactivity, and mannerism and posturing), and anxiety and
depressive symptoms (anxiety, depression, suicidality, and guilt)
(31). The reliability of the BPRS in our study was found to
be moderate for the BPRS total score [intraclass correlation
coefficient (ICC) 0.54]. It was also moderate for the symptom-
dimensions positive symptoms (ICC 0.71) and agitation mania
(ICC 0.72), while it was poor for negative symptoms (ICC 0.44)
and good for anxiety and depressive symptoms (ICC 0.78) (27).
The level of functioning was assessed using the Global
Assessment of Functioning (GAF) Scale (32) and the revised
version of the Practical and Social Functioning (PSF) scale (33).
We used the function scale from the split version of the GAF
(GAF-F) (34, 35), where the level of functioning (GAF-F) and
the severity of symptoms (GAF-S) are scored separately. The
GAF-F scale ranges from 0 to 100, and higher scores indicate
better functioning. The PSF revised is a 32-item clinician-rated
questionnaire giving eight subscales. Each item is given the score
0 (not able to perform), 1 (partly able to perform), or 2 (fully
able to perform). Each subscale comprises four items, with scores
ranging from 0 to 8. The PSF mean score is based on the scores
on these eight subscales and ranges from 0 to 8. Each subscale is a
separate factor with good internal consistency (Cronbach’s alpha
between 0.735 and 0.903) and acceptable face validity (Personal
communication, Ruud, 2014).
The clinicians assessed the participants’ problems related to
substance use with the AUS (36) and the DUS (37). Both scales
are rated on a 5-point scale from 1 (abstinent) to 5 (dependence
with institutionalization).
Self-Report Questionnaires
The participants also reported their use of alcohol and other
substances with the AUDIT (38) and the DUDIT (39). Both
questionnaires assess problematic use. The AUDIT comprises
10 items with a total score ranging from 0 to 40. The
DUDIT comprises 11 items, and the total score ranges from
0 to 44. Higher scores indicate more severe problems on
both questionnaires.
Quality of life was assessed using the Manchester Short
Assessment of Quality of Life (MANSA) (40). The MANSA is
a self-report questionnaire comprising 11 life domains and one
overall question regarding “General life satisfaction.” Each of
these 12 items are given a score from 1 (couldn’t be worse) to
7 (couldn’t be better), and the MANSA mean score ranges from
1.0 to 7.0.
Data Collection
Sociodemographic and clinical data were collected upon
enrollment into the ACT teams and after 2 years of follow-up.
Baseline data were collected from December 2009 to February
2012, while 2 years of follow-up data were collected from
December 2011 to February 2014. Onset of data collection
depended on when the team was established and when the
participants enrolled.
Data regarding the participants’ life situation and health,
psychiatric diagnosis and substance use (AUS and DUS), severity
of symptoms (BPRS-E), and level of functioning (GAF-F, PSF)
were obtained using clinician-rated instruments. The ACT
team members completed the forms based on information
from observations, interviews with participants, interviews with
relatives and professionals from other services, and from
electronic medical records. Information regarding the frequency
and the severity of substance use (AUDIT and DUDIT) and the
participants’ subjective quality of life (MANSA) was obtained
from self-report questionnaires that the participants completed
alone or together with an ACT team member.
Statistical Analyses
Sociodemographic and clinical characteristics upon enrollment
and after 2 years of follow-up were described as frequencies and
percentages for dichotomous and categorical variables and as
means and standard deviations (SD) for continuous variables.
Generalized linear mixed models were used to assess
changes in outcomes within the two groups (with and without
problematic substance use) and differences in changes between
the two groups for dichotomous variables. Linear mixed models
were estimated to assess changes in outcomes within the
groups and differences in changes between the two groups for
continuous variables. The models contained fixed effects for the
two time points (enrollment vs. follow-up), for substance use
status (Y/N), and for the interaction between these two. We
included random intercepts for teams to correctly adjust the
estimates for possible within-team correlations. We present the
results for dichotomous variables as within- and between-group
odds ratios (ORs) with 95% confidence interval (CI) and p-
values. The results for continuous variables are presented asmean
within-group changes and between-group differences in change
with corresponding 95%CI and p-values. All models were further
adjusted for age and gender.
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As reported in the Recruitment and Participants section,
six (7%) of the 84 participants who were classified as having
problematic substance use upon enrollment into ACT no longer
meet the criteria after 2 years of follow-up, and four (7%) of the
58 participants who did not meet the criteria upon enrollment
were classified as having problematic substance use 2 years
after. To test if our results were influenced by their status, we
performed sensitivity analyses by excluding these 10 participants
and reestimating the models above after.
Missing values for the PSF scale (n = 14, 0.3% of cases upon
enrollment and n= 10, 0.2% of cases at 2 years of follow-up), the
MANSA (n= 12, 0.5% of cases upon enrollment and n= 49, 2.2%
at 2 years of follow-up), and the BPRS scale (n = 0 cases upon
enrollment, n= 6, 0.2% at 2 years of follow-up) were imputed by
generating the empirical distribution for each item and drawing
a random number from that distribution to replace the missing
value. The process was repeated until all missing values were
imputed. The GAF-F scores were close to normally distributed,
and missing values (n = 4, 2.8% of cases upon enrollment and
n = 1, 0.7% of cases at 2 years of follow-up) were therefore
imputed by drawing a random number from the corresponding
normal distribution.
Missing values on demographic variables were not imputed.
The statistical analyses were performed by Statistical Package
for the Social Sciences (SPSS) version 25 and SAS software
version 9.4. All tests were two-sided, and the results with p-
values below 0.05 were considered statistically significant. No
adjustment for multiple testing was implemented.
Ethics
This study is a part of the national research-based evaluation of
ACT teams in Norway, which has been approved by the Regional
Committee forMedical andHealth Research Ethics, region South
East (ID: 2010/1196a), and by the Data Protection Officer at
Innlandet Hospital Trust, Norway.
RESULTS
Results from the descriptive analyses of the rehabilitation
outcomes among participants with and without problematic
substance use are reported inTable 1. Results from the regression
analyses regarding changes in outcomes within each group and
the difference in change between the groups are presented in
this section. A short summary of the results from the sensitivity
analyses is also provided.
Housing Situation
The general linear mixed models showed that the odds of having
a good housing situation increased significantly for participants
with problematic substance use only when adjusting for age and
gender (Table 2). For participants without problematic substance
use, the odds increased both in the unadjusted and the adjusted
model (Table 2).
When comparing the change between the two groups, we
found that the participants without problematic substance use
did not have a significantly greater increase in odds of having a
good housing situation compared to the group with problematic





Good housing situation N % N %
Substance use group 41 50.0 53 64.6
Non-substance use group 35 62.5 45 80.4
Meaningful daily activity
Substance use group 7 8.3 10 11.9
Non-substance use group 8 14.0 12 21.1
BPRS mean score* Mean SD Mean SD
Substance use group 2.60 0.86 2.38 0.81
Non-substance use group 2.24 0.66 2.09 0.69
BPRS positive symptoms*
Substance use group 2.65 1.34 2.57 1.31
Non-substance use group 2.23 1.14 2.14 1.12
BPRS negative symptoms*
Substance use group 2.43 1.14 2.07 0.96
Non-substance use group 2.59 1.18 2.34 0.99
BPRS agitation mania*
Substance use group 2.42 1.19 2.07 0.96
Non-substance use group 1.78 0.77 1.78 0.78
BPRS anxiety/depressive symptoms*
Substance use group 2.77 0.95 2.43 0.98
Non-substance use group 2.63 1.10 2.33 1.05
GAF-Function*
Substance use group 38.9 8.1 42.6 10.3
Non-substance use group 40.8 8.6 44.7 12.4
PSF score*
Substance use group 4.05 1.50 4.32 1.51
Non-substance use group 4.63 1.62 4.70 1.24
MANSA mean score
Substance use group 4.27 1.09 4.37 0.90
Non-substance use group 4.48 0.90 4.60 0.84
MANSA life in general
Substance use group 4.15 1.72 4.32 1.33
Non-substance use group 4.10 1.55 4.51 1.39
*Data from enrollment (in italic) have been published in a previous paper (28).
BPRS scores range from 1 to 7, with higher scores indicating more severe symptoms.
PSF scores range from 0 to 8, with higher scores indicating better functioning.
MANSA scores range from 1 to 7, with higher scores indicating more satisfaction.
BPRS, Brief Psychiatric Rating Scale; GAF, Global Assessment of Functioning Scale;
MANSA, Manchester Short Assessment of Quality of Life; PSF, Practical and
Social Functioning.
substance use (Table 3). Both the unadjusted and the adjusted
models showed the same result.
Meaningful Daily Activity
We found that the odds of having ameaningful daily activity after
2 years with ACT did not change significantly within the groups
(Table 2), and there was no significant difference in change
between the groups (Table 3) in either of the models (unadjusted
and adjusted).
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TABLE 2 | Within-group changes from ACT enrollment to 2 years of
follow-up—Dichotomous variables.
Unadjusted analysis Adjusted analysis*





2.52 1.07–5.94 0.035 2.63 1.10–6.28 0.030
Substance use
group





1.52 0.56–4.15 0.414 1.62 0.54–4.88 0.395
Substance use
group
1.52 0.53–4.32 0.433 1.34 0.46–3.91 0.589
*Adjusted for age and gender. The bold values highlight significant p-values (below 0.05).




Unadjusted analysis Adjusted analysis*
OR 95% CI p value OR 95% CI p value
Good housing
situation
1.49 0.49–4.10 0.515 1.37 0.47–4.04 0.567
Meaningful
daily activity
1.00 0.24–4.26 0.999 1.20 0.26–5.60 0.812
*Adjusted for age and gender.
Psychiatric Symptoms (Brief Psychiatric
Rating Scale–Expanded Version Scale)
Both the unadjusted and the adjusted model showed that
the participants with problematic substance use had less
severe symptoms (BPRS-E mean score), in particular less
negative, manic, and anxiety and depressive symptoms (BPRS-E
subscales) after 2 years with ACT (Table 4). Participants without
problematic substance use experienced a significant reduction of
anxiety and depressive symptoms (BPRS-E subscale) after 2 years
with ACT in both models (Table 4). Neither group experienced a
change in their level of positive symptoms.
When comparing the two groups, all analyses showed that
the reduction of manic symptoms was significantly greater
among participants with problematic substance use than
among participants without problematic substance use (Table 5).
Changes in other symptoms were not significantly different
between the two groups.
Level of Functioning (Global Assessment
of Functioning Scale–Function and
Practical and Social Functioning)
The global level of functioning (GAF-F) increased in both groups,
while the level of everyday practical and social functioning (PSF)
did not change significantly in either group (Table 4). Adjusting
for age and gender (Table 4) showed the same results.
Both the unadjusted and the adjusted models showed that the
changes in the global level of functioning (GAF-F) and everyday
practical and social functioning (PSF) were not significantly
different between the two groups (Table 5).
Subjective Quality of Life (Manchester
Short Assessment of Quality of Life)
There was no change in satisfaction with life in general or
the MANSA mean score among participants with problematic
substance use (Table 4) in both the unadjusted and the adjusted
model. Participants without problematic substance use reported
higher satisfaction with life in general (MANSA life in general;
Table 4) after 2 years, while the MANSA mean score did
not change significantly. The results remained the same after
adjusting for age and gender.
When comparing the two groups, we found that the change
in satisfaction with life in general was not significantly different
among participants with compared to participants without
problematic substance use (Table 5).
Summary of the Sensitivity Analyses
In the Recruitment and Participants section, we reported that the
status of problematic substance use changed for 10 of the 142
participants. We explored if this change of status influenced the
main results and performed unadjusted and adjusted sensitivity
analyses where these 10 participants were excluded.
In contrast to the main analyses, the sensitivity analyses
showed that the odds of having a good housing situation was not
higher after 2 years with ACT for participants with problematic
substance use after adjusting for age and gender (OR 1.90, 95%
CI 0.98–3.36, p= 0.059). We also found that participants without
problematic substance use experienced a significant reduction of
negative symptoms but only in the unadjusted analyses (BPRS
negative symptoms 0.34, 95% CI 0.03–0.65, p = 0.033). All other
results remained unchanged in the sensitivity analyses.
DISCUSSION
Themain purpose of this study was to explore if patients with and
without problematic substance use experienced improvements in
outcomes important for achieving and sustaining a meaningful
and independent life in the community after 2 years of follow-up
by ACT teams. Secondly, we aimed to explore if any changes in
the outcomes were different between the two groups.
Our study showed that the odds of having a good living
situation were higher at 2 years of follow-up than upon
enrollment into ACT for both groups, although it was only
significant when adjusting for age and gender among participants
with problematic substance use. Further studies should be
undertaken to explore the significance of age and gender on
living situation among persons with severe mental illness and
problematic substance use.
Both groups experienced a reduction of anxiety and depressive
symptoms, while only participants with problematic substance
use had less severe overall symptoms (BPRS-E mean score)
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TABLE 4 | Within-group changes from enrollment to 2 years of follow-up—Continuous variables.
Unadjusted analysis Adjusted analysis**
BPRS mean score Mean difference* 95% CI P-value Mean difference* 95% CI p-value
Non-substance use group 0.14 −0.06 to 0.34 0.165 0.12 −0.08 to 0.32 0.251
Substance use group 0.23 0.06 to 0.40 0.007 0.20 0.03 to 0.37 0.020
BPRS positive symptoms
Non-substance use group 0.07 −0.26 to 0.40 0.665 0.06 −0.27 to 0.40 0.708
Substance use group 0.09 −0.18 to 0.37 0.509 0.04 −0.24 to 0.31 0.784
BPRS negative symptoms
Non-substance use group 0.30 0.00 to 0.60 0.051 0.25 −0.06 to 0.56 0.111
Substance use group 0.32 0.07 to 0.58 0.011 0.30 0.05 to 0.56 0.019
BPRS agitation mania
Non-substance use group −0.01 −0.26 to 0.23 0.908 −0.09 −0.34 to 0.15 0.451
Substance use group 0.35 0.15 to 0.56 0.001 0.33 0.13 to 0.54 0.001
BPRS anxiety/depressive symptoms
Non-substance use group 0.30 0.03 to 0.556 0.031 0.31 0.04 to 0.58 0.028
Substance use group 0.35 0.12 to 0.57 0.002 0.32 0.09 to 0.54 0.005
GAF – Function
Non-substance use group −3.14 −5.56 to 0.64 0.015 −2.75 −5.30 to 0.20 0.036
Substance use group −2.76 −4.86 to 0.66 0.010 −2.61 −4.73 to 0.49 0.016
PSF score
Non-substance use group −0.08 −0.46 to 0.30 0.682 −0.03 −0.42 to 0.34 0.893
Substance use group −0.23 −0.55 to 0.09 0.164 −0.21 −0.54 to 0.12 0.221
MANSA mean score
Non-substance use group −0.16 −0.41 to 0.09 0.206 −0.17 −0.43 to 0.09 0.203
Substance use group −0.07 −0.29 to 0.16 0.570 −0.07 −0.31 to 0.16 0.541
MANSA life in general
Non-substance use group −0.51 −0.93 to 0.09 0.020 −0.54 −0.98 to 0.10 0.018
Substance use group −0.07 −0.46 to 0.32 0.719 −0.09 −0.49 to 0.31 0.671
*Positive mean difference indicated a reduction in scores, while negative mean difference indicated an increase in scores.
**Adjusted for age and gender.
BPRS, Brief Psychiatric Rating Scale; GAF, Global Assessment of Functioning Scale; MANSA, Manchester Short Assessment of Quality of Life; PSF, Practical and Social Functioning.
The bold values highlight significant p-values (below 0.05).
and negative and manic symptoms (BPRS-E subscales) at 2
years of follow-up. The level of positive symptoms did not
change for either group. The global level of functioning increased
for both groups, but neither group experienced improved
everyday practical and social functioning. Participants without
problematic substance use reported a higher level of satisfaction
with life in general at 2 years of follow-up, while participants
with problematic substance use did not report significantly
higher satisfaction. Neither group had significantly higher odds
of having a meaningful daily activity after 2 years of follow-up by
the teams.
Our results show that the only significant difference in change
was the greater reduction ofmanic symptoms among participants
with problematic substance use compared to participants
without problematic substance use. The significantly greater
reduction could partly be explained by the higher level of these
symptoms among participants with problematic substance use
upon enrollment. Participants without problematic substance
use problems had little manic symptoms at both time points.
An earlier report from this study showed that the participants
reported higher satisfaction with their housing situation after
2 years of follow-up. They were also more satisfied with their
employment status (having or not having competitive work)
but less satisfied with their physical health after 2 years with
ACT. We observed no changes in satisfaction with their mental
health (27). It is important to emphasize that neither group
experienced a deterioration of any outcomes in this study. This is
particularly of interest because the participants with problematic
substance use had ongoing and severe substance use problems
and fewer involuntary and total inpatient days during ACT
follow-up (28).
We expected that participants with problematic substance
use would experience less favorable changes than participants
without problematic substance use because of the ongoing
and severe substance use (28), in line with the study by
Ruppelt et al. (25). They found that patients without substance
dependence experienced greater improvements in symptoms,
level of functioning, and quality of life than patients with
substance dependence (25). An interesting point is that their
study included and secured IDDT to all participants with
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TABLE 5 | Between-group changes from enrollment to 2 years of follow-up—Continuous variables.
Continuous variables Unadjusted analysis Adjusted analysis**
Mean difference* 95% CI p-value Mean difference* 95% CI p-value
BPRS mean score 0.09 −0.18 to 0.35 0.511 0.08 −0.18 to 0.35 0.550
BPRS positive symptoms 0.02 −0.41 to 0.45 0.931 −0.03 −0.46 to 0.41 0.910
BPRS negative symptoms 0.02 −0.37 to 0.42 0.915 0.05 −0.35 to 0.44 0.801
BPRS agitation mania 0.37 0.04 to 0.69 0.030 0.43 0.11 to 0.75 0.010
BPRS anxiety/depressive symptoms 0.05 −0.30 to 0.40 0.787 0.01 −0.35 to 0.37 0.952
GAF-Function score 0.38 −2.92 to 3.69 0.821 0.14 −3.22 to 3.50 0.935
PSF score −0.15 −0.65 to 0.36 0.568 −0.18 −0.70 to 0.34 0.503
MANSA mean score 0.09 −0.25 to 0.43 0.589 0.10 −0.26 to 0.45 0.596
MANSA life in general 0.44 −0.15 to 1.02 0.144 0.46 −0.15 to 1.06 0.143
*Positive mean difference indicated a reduction in scores, while negative mean difference indicated an increase in scores.
**Adjusted for age and gender.
BPRS, Brief Psychiatric Rating Scale; GAF, Global Assessment of Functioning Scale; MANSA, Manchester Short Assessment of Quality of Life; PSF, Practical and Social Functioning.
The bold values highlight significant p-values (below 0.05).
substance use disorders during the follow-up period. We found
that most but not all patients in need of IDDT received such
treatment from the teams in our study (fidelity scores 3.0 at
12 months and 4.0 at 36 months, indicating that 60–89% of
the patients in need of IDDT also receive it from the team).
Additionally, we found that the availability of a substance use
specialist was moderate to high (mean fidelity scores on the
related items ranged 3.7–3.8) (41), but there were large variations
between the teams (28), as described in Setting. Although some of
the elements of IDDT were only moderately implemented in the
ACT teams in this study, participants with problematic substance
use experienced improvements similar to participants without
problematic substance use.
However, the lack of differences in changes between
the groups in our study is in line with a recent multisite
randomized controlled trial by Urbanoski et al. (42). They
investigated differences in mental health symptoms, community
functioning, and quality of life among patients with and
without co-occurring substance use disorder receiving Housing
First in ACT or intensive case management compared to
patients receiving treatment as usual (42). As in our study,
the level of substance use remained high during the study
period (43), but both patients with and without substance use
problems experienced improvements, and the difference
was not greater among patients without substance use
problems (42).
A service delivery framework, such as the ACT model,
is not by itself sufficient or independent of the rest of the
service system. The teams need to collaborate closely with
other service providers and agencies. For example, the ACT
model emphasizes the importance of rehabilitation services
to improve patients’ possibilities for an independent living in
the community, including systematically providing services to
support patients’ education and employment, such as the model
for Supported Employment & Education (20, 44). In our study,
we found that the odds of having a meaningful daily activity
did not increase for our participants after 2 years with ACT
follow-up. One possible explanation may be the organization of
health and welfare services in Norway. Social services typically
provide financial, vocational, and educational support, while
mental health care traditionally focuses on symptom severity
and level of functioning and treatment targeting these. Any
collaboration between these services occurs on a random basis,
and this fragmentation could be an obstacle for the ACT teams
to provide vocational and educational services. Additionally, a
model that primarily is based on the person’s desire to work as
the only eligibility criterion is rather new in the Norwegian care
system. Such new models might be more difficult to implement,
particularly in the start-up phase, as suggested by Odden et al.
(41). Another possible explanation may also be that the teams
were in their start-up phase during the first part of the study and
had a stronger focus on crisis management and everyday coping
and less focus on long-term perspective of the treatment, such as
education/employment and illness management. This hypothesis
may be supported by the lower level of fidelity on the items for
vocational service and illness management at 12 and 36 months
of operation [EP1 mean scores (SD) 3.0 ± 1.3–4.0 ± 1.0, EP2
mean scores 3.3 ± 1.6–3.6 ± 1.6, EP3 mean scores 1.0 ± 0.0–
1.1 ± 0.3, EP5 mean scores 2.3 ± 0.7–2.5 ± 0.9] (41). However,
for services to adapt to a more recovery-oriented approach,
it is important that these aspects also get attention and focus
during treatment and follow-up. It is an important political and
administrative task to make sure that employment, education,
and illness management is being brought to the attention of the
mental health care providers.
Although we cannot exclude the possibility that the changes
in part is caused by regression to the mean, it may also suggest
that the ACT model can provide an important framework
for delivering evidence-based psychosocial services in the
community in line with the recommendations from clinical
personnel and researchers (11, 45–47), the WHO (14),
and the UN (15). Patients with severe mental illness and
complex and comprehensive needs often receive inadequate
rehabilitation- and recovery-oriented services and have
difficulties in achieving and sustaining an independent life in the
community (11, 45, 47).
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STRENGTHS AND LIMITATIONS
The strength of our study is the inclusion of all the 12
first ACT teams that were established in Norway, and the
geographical representation of both urban and rural areas.
However, the observational and exploratory design does not
allow us to draw causative conclusions. We also did not have
a control group. Due to the multiple outcome variables used
in our analyses, we increase the risk for false-positive findings.
However, as this field is still in need of an increased knowledge
regarding rehabilitation for persons with severe mental illness,
we have chosen to present our findings as they are, but they
should be interpreted with caution. We also must emphasize
the possibilities of our study being underpowered as some
of the results showed close to a significant change in some
outcome after 2 years with ACT. Furthermore, we recruited
only 42% of all patients who were enrolled into the ACT teams
during their first year. There were more nonparticipants than
participants with co-occurring substance use problems, and
the participants had less severe symptoms and higher level of
functioning than the nonparticipants (28). Therefore, we cannot
exclude the possibility that the improvements experienced by
our sample could be biased by an underrepresentation of a
population with more severe problems. Additionally, this study
has a prospective pre–post design with data collection at two
time points (enrollment and 24 months), providing information
regarding the participants’ situation at these two time points. A
more frequent data collection time (e.g., every 6 months) would
have provided the opportunity to explore fluctuations over time.
By dichotomizing the outcome variables Housing Situation
and Meaningful Daily Activity, we reduce the variance, but some
categories had small numbers (<5) of participants; hence, the
dichotomization was performed to avoid possible type II-errors.
Finally, the clinical-reported data were collected by the ACT team
members, thus many persons were involved in the data collection
and the assessments were not blinded. This could have influenced
the reliability of some of the scores.
CONCLUSION
Our study shows that not only participants without problematic
substance use experience improvements in several areas
relevant for rehabilitation after 2 years of ACT services. Also,
participants with problematic substance use experienced
significant improvements in several areas, and the improvements
were similar in both groups. It is important to remember that
the ACT population typically is a marginalized group that does
not receive adequate and appropriate treatment, particularly
those with co-occurring substance use. Our results support the
understanding that ACT has a place in the continued effort
toward adequate, integrated, and comprehensive community
services that provide evidence-based interventions aiming
to empower and to help patients with severe mental illness
to achieve and to sustain an independent life. And most
importantly, this includes persons with severe substance
use problems.
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